{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T20:23:50Z","timestamp":1773519830269,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170800"],"award-info":[{"award-number":["82170800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","award":["SRSP2021002"],"award-info":[{"award-number":["SRSP2021002"]}],"id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","award":["SRSP2021012"],"award-info":[{"award-number":["SRSP2021012"]}],"id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020KTSCX024"],"award-info":[{"award-number":["2020KTSCX024"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010928"],"award-info":[{"award-number":["2021A1515010928"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.intimp.2023.110494","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T04:34:36Z","timestamp":1686890076000},"page":"110494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["MIF promotes Th17 cell differentiation in Hashimoto's thyroiditis by binding HVEM and activating NF-\u03baB signaling pathway"],"prefix":"10.1016","volume":"121","author":[{"given":"Zijian","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guozhi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaosheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanshi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-2502","authenticated-orcid":false,"given":"Xiaokang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2023.110494_b0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s40618-020-01477-1","article-title":"An update on the pathogenesis of Hashimoto's thyroiditis","volume":"44","author":"Weetman","year":"2021","journal-title":"J. Endocrinol. Invest."},{"issue":"12","key":"10.1016\/j.intimp.2023.110494_b0010","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.3390\/ijms23126580","article-title":"Metabolic characteristics of Hashimoto\u2019s thyroiditis patients and the role of microelements and diet in the disease management-an overview","volume":"23","author":"Mikulska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.110494_b0015","doi-asserted-by":"crossref","unstructured":"F. Ragusa, P. Fallahi, G. Elia, D. Gonnella, S.R. Paparo, C. Giusti, L.P. Churilov, S.M. Ferrari, A. Antonelli, Hashimotos' thyroiditis: epidemiology, pathogenesis, clinic and therapy, Best Pract. Res. Clin. Endocrinol. Metab. 33(6) (2019) 101367, doi: 10.1016\/j.beem.2019.101367.","DOI":"10.1016\/j.beem.2019.101367"},{"key":"10.1016\/j.intimp.2023.110494_b0020","doi-asserted-by":"crossref","unstructured":"M. Ralli, D. Angeletti, M. Fiore, V. D'Aguanno, A. Lambiase, M. Artico, M. de Vincentiis, A. Greco, Hashimoto's thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation, Autoimmun. Rev. 19(10) (2020) 102649, doi: 10.1016\/j.autrev.2020.102649.","DOI":"10.1016\/j.autrev.2020.102649"},{"key":"10.1016\/j.intimp.2023.110494_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.959477","article-title":"The changes in peripheral blood Th17 and Treg ratios in Hashimoto's thyroiditis are accompanied by differential PD-1\/PD-L1 expression","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"12","key":"10.1016\/j.intimp.2023.110494_b0030","doi-asserted-by":"crossref","first-page":"bqab190","DOI":"10.1210\/endocr\/bqab190","article-title":"Simulation model for Hashimoto autoimmune thyroiditis disease","volume":"162","author":"Salazar-Viedma","year":"2021","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.intimp.2023.110494_b0035","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1210\/en.2009-0434","article-title":"T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice","volume":"150","author":"Horie","year":"2009","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.intimp.2023.110494_b0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.clim.2013.10.001","article-title":"Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients","volume":"149","author":"Li","year":"2013","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110494_b0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12020-017-1361-y","article-title":"Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders","volume":"57","author":"Vitales-Noyola","year":"2017","journal-title":"Endocrine"},{"issue":"7","key":"10.1016\/j.intimp.2023.110494_b0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","article-title":"The immunobiology of MIF: function, genetics and prospects for precision medicine","volume":"15","author":"Kang","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110494_b0055","doi-asserted-by":"crossref","unstructured":"R.A. de Azevedo, E. Shoshan, S. Whang, G. Markel, A.R. Jaiswal, A. Liu, M.A. Curran, L.R. Travassos, M. Bar-Eli, MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma, Oncoimmunology 9(1) (2020) 1846915, doi: 10.1080\/2162402X.2020.1846915.","DOI":"10.1080\/2162402X.2020.1846915"},{"issue":"3","key":"10.1016\/j.intimp.2023.110494_b0060","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/med.21385","article-title":"Targeting MIF in cancer: therapeutic strategies, current developments, and future opportunities","volume":"36","author":"O'Reilly","year":"2016","journal-title":"Med. Res. Rev."},{"issue":"9","key":"10.1016\/j.intimp.2023.110494_b0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/14728222.2019.1656718","article-title":"Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus","volume":"23","author":"Bilsborrow","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"issue":"11","key":"10.1016\/j.intimp.2023.110494_b0070","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1096\/fj.15-273904","article-title":"MIF interacts with CXCR7 to promote receptor internalization, ERK1\/2 and ZAP-70 signaling, and lymphocyte chemotaxis","volume":"29","author":"Alampour-Rajabi","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2023.110494_b0075","doi-asserted-by":"crossref","unstructured":"J.T. Noe, R.A. Mitchell, MIF-dependent control of tumor immunity, Front. Immunol. 11 (2020) 609948, doi: 10.3389\/fimmu.2020.609948.","DOI":"10.3389\/fimmu.2020.609948"},{"key":"10.1016\/j.intimp.2023.110494_b0080","doi-asserted-by":"crossref","unstructured":"H. Xue, Y. Yang, Y. Zhang, S. Song, L. Zhang, L. Ma, T. Yang, H. Liu, Macrophage migration inhibitory factor interacting with Th17 cells may be involved in the pathogenesis of autoimmune damage in Hashimoto's thyroiditis, Mediators Inflamm. 2015 (2015) 621072, doi: 10.1155\/2015\/621072.","DOI":"10.1155\/2015\/621072"},{"issue":"18","key":"10.1016\/j.intimp.2023.110494_b0085","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.3390\/jcm10184034","article-title":"Preoperative serum macrophage migration inhibitory factor level correlates with surgical difficulty and outcome in patients with autoimmune thyroiditis","volume":"10","author":"Chong","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110494_b0090","doi-asserted-by":"crossref","first-page":"L6","DOI":"10.1152\/ajplung.00288.2020","article-title":"Inhibition of macrophage migration inhibitory factor (MIF) as a therapeutic target in bleomycin-induced pulmonary fibrosis rats","volume":"321","author":"Luo","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.intimp.2023.110494_b0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cyto.2018.11.014","article-title":"Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients","volume":"115","author":"Hern\u00e1ndez-Palma","year":"2019","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.intimp.2023.110494_b0100","first-page":"R97","article-title":"Clinical associations of serum interleukin-17 in systemic lupus erythematosus,\u00a0 Arthritis Res.","volume":"15","author":"Vincent","year":"2013","journal-title":"Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.110494_b0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2567.2008.02879.x","article-title":"Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells","volume":"126","author":"Stojanovi\u0107","year":"2009","journal-title":"Immunology"},{"issue":"42","key":"10.1016\/j.intimp.2023.110494_b0110","doi-asserted-by":"crossref","first-page":"35484","DOI":"10.1074\/jbc.M112.367532","article-title":"Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients","volume":"287","author":"Li","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2023.110494_b0115","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.coi.2011.08.008","article-title":"TNF Superfamily Networks: Bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14)","volume":"23","author":"Ware","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110494_b0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-065X.2009.00783.x","article-title":"The CD160, BTLA, LIGHT\/HVEM pathway: a bidirectional switch regulating T-cell activation","volume":"229","author":"Cai","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2023.110494_b0125","doi-asserted-by":"crossref","unstructured":"N. Malissen, N. Macagno, S. Granjeaud, C. Granier, V. Moutardier, C. Gaudy-Marqueste, N. Habel, M. Mandavit, B. Guillot, C. Pasero, E. Tartour, R. Ballotti, J.J. Grob, D. Olive, HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma, Oncoimmunology 8 (12) (2019) e1665976, doi:10.1080\/2162402X.2019.1665976.","DOI":"10.1080\/2162402X.2019.1665976"},{"issue":"4","key":"10.1016\/j.intimp.2023.110494_b0130","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.coph.2012.03.001","article-title":"The HVEM network: New directions in targeting novel costimulatory\/co-inhibitory molecules for cancer therapy","volume":"12","author":"Pasero","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"issue":"15","key":"10.1016\/j.intimp.2023.110494_b0135","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1073\/pnas.0902115106","article-title":"Unconventional ligand activation of herpesvirus entry mediator signals cell survival","volume":"106","author":"Cheung","year":"2009","journal-title":"PNAS"},{"issue":"19","key":"10.1016\/j.intimp.2023.110494_b0140","doi-asserted-by":"crossref","first-page":"14307","DOI":"10.1074\/jbc.275.19.14307","article-title":"The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells","volume":"275","author":"Rooney","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2023.110494_b0145","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1084\/jem.20110462","article-title":"The Th17 immune response is controlled by the Rel-ROR\u03b3-ROR\u03b3 T transcriptional axis","volume":"208","author":"Ruan","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110494_b0150","article-title":"Single-cell RNA-seq analysis reveals dysregulated cell-cell interactions in a tumor microenvironment related to HCC development","volume":"2022","author":"Liu","year":"2022","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.intimp.2023.110494_b0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-065X.2011.01064.x","article-title":"The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation","volume":"244","author":"Steinberg","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2023.110494_b0160","article-title":"Cellular interaction analysis characterizing immunosuppressive microenvironment functions in MM tumorigenesis from precursor stages","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Genet."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923008172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923008172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:55:54Z","timestamp":1761587754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923008172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":32,"alternative-id":["S1567576923008172"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110494","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MIF promotes Th17 cell differentiation in Hashimoto's thyroiditis by binding HVEM and activating NF-\u03baB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110494"}}